Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib With or Without Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer
NCT00080743Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- Jan 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in breast cancer, sponsored by Dartmouth Health. Started Jan 2004; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00080743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080743.